164 related articles for article (PubMed ID: 3026018)
1. Efficacy and safety of sequential treatment with parenteral sulbactam/ampicillin and oral sultamicillin for skeletal infections in children.
Aronoff SC; Scoles PV; Makley JT; Jacobs MR; Blumer JL; Kalamchi A
Rev Infect Dis; 1986; 8 Suppl 5():S639-43. PubMed ID: 3026018
[TBL] [Abstract][Full Text] [Related]
2. Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae.
Pressler T; Pedersen SS; Christiansen L; Szaff M; Koch C; Høiby N
J Antimicrob Chemother; 1986 Apr; 17(4):529-33. PubMed ID: 3011725
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
[TBL] [Abstract][Full Text] [Related]
4. Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
Ball AP; Fox C; Ghosh D
J Antimicrob Chemother; 1984 Oct; 14(4):395-401. PubMed ID: 6094422
[TBL] [Abstract][Full Text] [Related]
5. Sultamicillin in the treatment of superficial skin and soft tissue infections in children.
Goldfarb J; Aronoff SC; Jaffe A; Reed MD; Blumer JL
Antimicrob Agents Chemother; 1987 Apr; 31(4):663-4. PubMed ID: 3038003
[TBL] [Abstract][Full Text] [Related]
6. Sultamicillin (ampicillin-sulbactam) in the treatment of acute otitis media in children.
Kaleida PH; Bluestone CD; Blatter MM; Reisinger KS; Wucher FP; Fall PA; Rohn DD
Pediatr Infect Dis; 1986; 5(1):33-8. PubMed ID: 3003716
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of sulbactam/ampicillin in pediatric infections caused by ampicillin-resistant or penicillin-resistant organisms.
Syriopoulou V; Bitsi M; Theodoridis C; Saroglou I; Krikos X; Tzanetou K
Rev Infect Dis; 1986; 8 Suppl 5():S630-3. PubMed ID: 3026016
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bactericidal activity of sultamicillin in infants and children.
Ginsburg CM; McCracken GH; Olsen K; Petruska M
J Antimicrob Chemother; 1985 Mar; 15(3):345-51. PubMed ID: 2987174
[TBL] [Abstract][Full Text] [Related]
9. Sulbactam/ampicillin in the treatment of acute epiglottitis in children.
Wald E; Reilly JS; Bluestone CD; Chiponis D
Rev Infect Dis; 1986; 8 Suppl 5():S617-9. PubMed ID: 3026014
[TBL] [Abstract][Full Text] [Related]
10. An open, comparative study of sulbactam plus ampicillin vs. cefotaxime as initial therapy for serious soft tissue and bone and joint infections.
Löffler L; Bauernfeind A; Keyl W; Hoffstedt B; Piergies A; Lenz W
Rev Infect Dis; 1986; 8 Suppl 5():S593-8. PubMed ID: 3026009
[TBL] [Abstract][Full Text] [Related]
11. Activity of sulbactam/ampicillin in screening and discriminative animal models of infection.
English AR; Girard D; Cimochowski C; Faiella J; Retsema JA; Lynch JE
Rev Infect Dis; 1986; 8 Suppl 5():S535-42. PubMed ID: 3026002
[TBL] [Abstract][Full Text] [Related]
12. Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections.
Chang ST; Chung HY; Pai SD; Lee JH
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):175S-178S. PubMed ID: 2686917
[TBL] [Abstract][Full Text] [Related]
13. Worldwide clinical experience with sultamicillin.
Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
[TBL] [Abstract][Full Text] [Related]
14. Clinical, bacteriological and pharmacokinetic results from an open trial of sultamicillin in patients with acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; van Noord JA
J Antimicrob Chemother; 1984 Feb; 13(2):161-70. PubMed ID: 6323377
[TBL] [Abstract][Full Text] [Related]
15. Two regimens of sultamicillin in treating uncomplicated gonorrhoea.
Farthing C; Thin RN; Smith S; Phillips I
Genitourin Med; 1985 Feb; 61(1):44-7. PubMed ID: 3002961
[TBL] [Abstract][Full Text] [Related]
16. Ampicillin/sulbactam (Unasyn).
Med Lett Drugs Ther; 1987 Aug; 29(747):79-81. PubMed ID: 3039328
[No Abstract] [Full Text] [Related]
17. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Friedel HA; Campoli-Richards DM; Goa KL
Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind comparison of sulbactam/ampicillin and clindamycin for the treatment of aerobic and aerobic-anaerobic infections.
Reinhardt JF; Johnston L; Ruane P; Johnson CC; Ingram-drake L; MacDonald K; Ward KW; Mathisen G; George WL; Finegold SM
Rev Infect Dis; 1986; 8 Suppl 5():S569-75. PubMed ID: 3026005
[TBL] [Abstract][Full Text] [Related]
19. Sultamicillin (sulbactam/ampicillin) versus amoxycillin in the treatment of acute otitis media in children.
Rodriguez WJ; Khan WH; Sait T; Chhabra OP; Guarinello A; Smith AW; Ahmad S
J Int Med Res; 1990; 18 Suppl 4():78D-84D. PubMed ID: 2282972
[TBL] [Abstract][Full Text] [Related]
20. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
